DUBLIN – (COMMERCIAL THREAD)–The “Blood Glucose Monitoring Devices Market – Global Outlook and Forecast 2021-2026” report was added to ResearchAndMarkets.com offer.

In-depth analysis and data-driven insights into the impact of COVID-19 included in this report on Global Blood Glucose Monitoring Devices Market

The global Blood Glucose Monitoring Devices market revenue is expected to grow at 12% CAGR during the period 2021-2026.

The diabetes surveillance industry is growing at a steady pace due to the increasing prevalence of diabetes and the increase in chronic diseases. Globally, the incidence of diabetes has increased at an alarming rate due to changing lifestyles, increasing alcohol consumption and increasing numbers of smokers. In emerging markets and newly industrialized countries, the number of new cases of diabetes is expected to increase significantly in the coming years. Therefore, blood sugar monitoring has been shown to be essential for the management of the disease. The growing awareness of diabetes is likely to increase the demand for the blood sugar monitoring devices market.

The following factors are likely to contribute to the growth of the blood glucose monitoring devices market during the forecast period:

• Increase in the diabetic population

• Increased demand for self-monitoring devices due to the Covid-19 pandemic

• Emergence of non-invasive blood glucose monitoring devices

The study examines the current scenario of the Blood Glucose Monitoring Devices market and its market dynamics for the period 2020-2026. It covers a detailed overview of several catalysts, restraints and trends for market growth. The report presents both demand and supply aspects of the market. It profiles and reviews the top companies and other leading companies operating in the market.

Global Blood Glucose Monitoring Devices Market Segmentation

The global Blood Glucose Monitoring Devices market research report comprises detailed segmentation by product, end users, usage, distribution channels, geography. The market for conventional blood glucose monitoring devices accounted for a share of over 78%. One of the main factors contributing to the growth of conventional blood glucose monitoring devices is the increase in the diabetic population worldwide, which is expected to reach over 578 million by 2030. The increase in obesity and the increasing aging of the population in developed countries are other major factors. that are indirectly influencing the growth of the Blood Glucose Monitoring Devices market. Test strips, lancets and lancing devices, along with readers and software are the major components covered by the conventional blood glucose monitoring devices market.

A high prevalence of diabetes and changes in lifestyle have increased the use of personal blood glucose monitoring devices. The need to monitor blood sugar increases the use of these devices. Technological advancements have played an important role in the proliferation of BGM devices. The introduction of wireless blood glucose monitoring systems, which can be used on a smartphone using Wi-Fi protocols, helps patients monitor their blood sugar remotely. In developed countries such as UK, Spain, Germany, Italy and UK, blood glucose meters and CGM self-monitoring devices are fully reimbursed, making these devices cost effective and thus stimulating patient use.

The online channel is growing significantly in developing countries like India and China. Increased competition among online sellers has affected the cost of the device, with steep discounts enticing consumers to opt for online stores. With the increasing use of smartphones in developing countries, the online distribution channel is likely to become an important distribution channel. Therefore, the strong preference for in-line channels bodes well for the growth of medical devices, especially blood glucose monitors.

The individual segment accounted for the largest share of the glucose monitoring devices market due to the wide acceptance of self-monitoring devices around the world. These devices are mostly covered by insurance companies in several developed and developing countries. Morbidity and mortality from diabetes are extremely high in underdeveloped countries due to poor adherence to global diabetes guidelines. Therefore, the scope of the self-test is likely to increase in patients with diabetes. In addition, the introduction of advanced devices with remote monitoring functions has encouraged patients to use personal blood glucose monitors.

Answers to key questions

1. What is the estimated global glucose monitoring devices market size forecast in 2026?

2. What is the opportunity for the Non-invasive Glucometers Market?

3. What is the growth projection for the Continuous Blood Glucose Monitoring Devices market share?

4. Who are the major players in the Blood Glucose Monitoring Market?

5. What is the Self-Monitoring of Blood Glucose (SMBG) market share?

Market dynamics

Opportunities and trends

• Increase in the diabetic population

• Covid-19 pandemic increases demand for self-monitoring glucose devices

• Urgency of non-invasive blood glucose monitoring devices

Growth facilitators

• Technological Advances in Blood Glucose Monitoring

• New product launches

• Availability of mobile apps and data integration platforms

Constraints

• Limitations associated with BGM devices

• Large pool of undiagnosed people

• High cost of blood glucose monitors

Leading suppliers

• Abbott

• Hoffmann-La Roche

• DexCom

• Medtronic

• Ascensia Diabetes Care Holdings

• LifeScan

Other important suppliers

• 77 Elektronika Kft

• Menarini diagnosis

• ARKRAY

• ApexBio

• ACON

• AgaMatrix

• International Alliance

• Andon Health

• Braun Melsungen

• Bionime

• Butter

• Bioptik

• EASYMAX

• ForaCare

• Hannox International

• Integrity applications

• i-SENS

• MED CONFIDENCE

• Nova Biomedical

• Nemaura

• OK Biotech

• OSANG Health

• Sanofi

• Terumo

• Trividia Health

• Rossmax International

• Ypsomed

For more information on this report, visit https://www.researchandmarkets.com/r/ag6q1v